Evidence map›Paper›PMID 37985787›Full record

ArticleMolecular psychiatry2024

Electroconvulsive therapy-induced volumetric brain changes converge on a common causal circuit in depression.

Miklos Argyelan, Zhi-De Deng, Olga Therese Ousdal, Leif Oltedal, Brian Angulo, Mate Baradits, Andrew J Spitzberg, Ute Kessler, Alexander Sartorius, Annemiek Dols and 34 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Molecular psychiatry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Targeting depression circuitry with H1 coil Transcranial Magnetic Stimulation: a retrospective circuit mapping study.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2025
    Article
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

44 authors at 20 institutions in 11 countries.

Miklos ArgyelanFeinstein Institutes for Medical Research, Institute of Behavioral Science, Manhasset, NY, USA. margyela@northwell.edu.ORCID 0000-0002-7254-1776
Zhi-De DengNoninvasive Neuromodulation Unit, Experimental Therapeutics and Pathophysiology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0001-8925-0871
Olga Therese OusdalDepartment of Biomedicine, Faculty of Medicine, University of Bergen, Bergen, Norway.
Leif OltedalDepartment of Clinical Medicine, University of Bergen, Bergen, Norway.
Brian AnguloFeinstein Institutes for Medical Research, Institute of Behavioral Science, Manhasset, NY, USA.
Mate BaraditsDepartment of Psychiatry and Psychotherapy, Semmelweis University, Budapest, Hungary.
Andrew J SpitzbergThe Zucker Hillside Hospital, Glen Oaks, NY, USA.ORCID 0000-0001-9379-2075
Ute KesslerDepartment of Psychiatry, Haukeland University Hospital, University of Bergen, Bergen, Hungary.ORCID 0000-0002-2002-5518
Alexander SartoriusDepartment of Psychiatry and Psychotherapy, Central Institute of Mental Health (CIMH), Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany.ORCID 0000-0002-1243-3693
Annemiek DolsDepartment of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, The Netherlands.
Katherine L NarrDepartment of Neurology, University of California Los Angeles, Los Angeles, CA, USA.
Randall EspinozaDepartment of Psychiatry and Biobehavioral Sciences, University of California Los Angeles, Los Angeles, CA, USA.ORCID 0000-0003-2895-4212
Jeroen A van WaardeRijnstate, Arnhem, the Netherlands.ORCID 0000-0001-6792-5727
Indira TendolkarDonders Institute for Brain, Cognition and Behavior, Department of Psychiatry, Nijmegen, the Netherlands.ORCID 0000-0003-3171-3671
Philip van EijndhovenDonders Institute for Brain, Cognition and Behavior, Department of Psychiatry, Nijmegen, the Netherlands.
Guido A van WingenAmsterdam UMC location University of Amsterdam, Department of Psychiatry, Amsterdam, The Netherlands.ORCID 0000-0003-3076-5891
Akihiro TakamiyaDepartment of Neuropsychiatry Keio University School of Medicine, Tokyo, Japan.ORCID 0000-0003-2985-6673
Taishiro KishimotoHills Joint Research Laboratory for Future Preventive Medicine and Wellness, Keio University School of Medicine, Tokyo, Japan.ORCID 0000-0003-0557-8648
Martin B JorgensenPsychiatric Center Copenhagen and Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-1321-8901
Anders JorgensenPsychiatric Center Copenhagen and Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0001-6012-6965
Olaf B PaulsonNeurobiological Research Unit Rigshospitalet and Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0001-7712-8596
Antoine YrondiService de Psychiatrie et Psychologie Médicale, Centre Expert Dépression Résistante, Fondation Fondamental, CHU Toulouse, ToNIC, Toulouse NeuroImaging Center, Univerité de Toulouse, Inserm, UPS, Toulouse, France.ORCID 0000-0002-2650-6080
Patrice PéranToNIC, Toulouse NeuroImaging Center, Univeristé de Toulouse, Inserm, UPS, Toulouse, France.
Carles Soriano-MasDepartment of Social Psychology and Quantitative Psychology, Universitat de Barcelona-UB, Barcelona, Spain.ORCID 0000-0003-4574-6597
Narcis CardonerCIBERSAM, Carlos III Health Institute, Madrid, Spain.ORCID 0000-0001-9633-0888
Marta CanoCIBERSAM, Carlos III Health Institute, Madrid, Spain.
Linda van DiermenDepartment of Psychiatry, Collaborative Antwerp Psychiatric Research Institute (CAPRI), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Didier SchrijversDepartment of Psychiatry, Collaborative Antwerp Psychiatric Research Institute (CAPRI), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Jean-Baptiste BelgeDepartment of Psychiatry, Collaborative Antwerp Psychiatric Research Institute (CAPRI), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium.
Louise EmsellGeriatric Psychiatry, University Psychiatric Center-KU Leuven, Leuven, Belgium.ORCID 0000-0003-0011-4158
Filip BouckaertGeriatric Psychiatry, University Psychiatric Center-KU Leuven, Leuven, Belgium.
Mathieu VandenbulckeGeriatric Psychiatry, University Psychiatric Center-KU Leuven, Leuven, Belgium.
Maximilian KiebsSchool of Medicine & Health Sciences University Hospital Oldenburg, Oldenburg, Germany.ORCID 0000-0002-4216-2679
René HurlemannSchool of Medicine & Health Sciences University Hospital Oldenburg, Oldenburg, Germany.
Peter Cr MuldersDonders Institute for Brain, Cognition and Behavior, Department of Psychiatry, Nijmegen, the Netherlands.ORCID 0000-0002-7867-5513
Ronny RedlichDepartment of Psychology, University of Halle, Halle, Germany.
Udo DannlowskiDepartment of Translational Psychiatry, University of Muenster, Muenster, Germany.ORCID 0000-0002-0623-3759
Erhan KavakbasiDepartment of Mental Health, University of Muenster, Muenster, Germany.
Michael D KritzerDepartment of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Kristen K EllardDepartment of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Joan A CamprodonDepartment of Psychiatry, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Georgios PetridesThe Zucker Hillside Hospital, Glen Oaks, NY, USA.
Anil K MalhotraFeinstein Institutes for Medical Research, Institute of Behavioral Science, Manhasset, NY, USA.
Christopher C AbbottDepartment of Psychiatry, University of New Mexico, Albuquerque, NM, USA.ORCID 0000-0001-6884-2464
Radboud University Nijmegen · NLFeinstein Institute for Medical Research · USHarvard University · USHaukeland University Hospital · NOKU Leuven · BEUniversity of Copenhagen · DKInstituto de Salud Carlos III · ESKeio University · JPUniversité Toulouse III - Paul Sabatier · FRUniversity of Antwerp · BEUniversity of California, Los Angeles · USZucker Hillside Hospital · USAmsterdam Neuroscience · NLHeidelberg University · DENational Institutes of Health · USRijnstate Hospital · NLSemmelweis University · HUUniversitat Autònoma de Barcelona · ESUniversity Hospital Bonn · DEUniversity Medical Center Utrecht · NL

Funding

Non-invasive Neuromodulation Unit (NNU)ZIAMH002955 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI ZARATE, CARLOS · 2016 to 2025
$40.3M
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)R01MH128690 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Katherine L Narr · 2022 to 2026
$2.9M
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)R01MH128692 · NIMH · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Christopher C Abbott · 2022 to 2026
$2.6M
Electroconvulsive therapy amplitude titration for improved clinical outcomes in late-life depressionR33MH125126 · NIMH · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI ABBOTT, CHRISTOPHER C · 2023 to 2025
$2.0M
ECT current amplitude and medial temporal lobe engagementU01MH111826 · NIMH · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI ABBOTT, CHRISTOPHER C · 2017 to 2019
$1.5M
Electroconvulsive therapy amplitude titration for improved clinical outcomes in late-life depressionR61MH125126 · NIMH · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI ABBOTT, CHRISTOPHER C · 2021 to 2022
$1.4M
Neural Biomarkers of ECT Response in SchizophreniaK23MH120504 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI ARGYELAN, MIKLOS · 2020 to 2023
$781k
ECT current amplitude and medial temporal lobe engagementR01MH111826 · NIMH · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI ABBOTT, CHRISTOPHER C · 2016 to 2016
$522k
Electrical Field and Neuroimaging Based Prediction of ECT Induced Clinical and Cognitive EffectsR21MH119616 · NIMH · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI ARGYELAN, MIKLOS · 2019 to 2020
$454k
Deutsche Forschungsgemeinschaft (German Research Foundation) RE4458/1-1 to RRNIMH NIH HHS K23 MH120504NIMH NIH HHS R01 MH111826NIMH NIH HHS R01 MH128690NIMH NIH HHS R01 MH128692NIMH NIH HHS R21 MH119616NIMH NIH HHS R33 MH125126NIMH NIH HHS R61 MH125126NIMH NIH HHS U01 MH111826U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) K23MH120504U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) MH111826U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) MH128690U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) R21MH119616
6 · The paper itself

Abstract

Neurostimulation is a mainstream treatment option for major depression. Neuromodulation techniques apply repetitive magnetic or electrical stimulation to some neural target but significantly differ in their invasiveness, spatial selectivity, mechanism of action, and efficacy. Despite these differences, recent analyses of transcranial magnetic stimulation (TMS) and deep brain stimulation (DBS)-treated individuals converged on a common neural network that might have a causal role in treatment response. We set out to investigate if the neuronal underpinnings of electroconvulsive therapy (ECT) are similarly associated with this causal depression network (CDN). Our aim here is to provide a comprehensive analysis in three cohorts of patients segregated by electrode placement (N = 246 with right unilateral, 79 with bitemporal, and 61 with mixed) who underwent ECT. We conducted a data-driven, unsupervised multivariate neuroimaging analysis Principal Component Analysis (PCA) of the cortical and subcortical volume changes and electric field (EF) distribution to explore changes within the CDN associated with antidepressant outcomes. Despite the different treatment modalities (ECT vs TMS and DBS) and methodological approaches (structural vs functional networks), we found a highly similar pattern of change within the CDN in the three cohorts of patients (spatial similarity across 85 regions: r = 0.65, 0.58, 0.40, df = 83). Most importantly, the expression of this pattern correlated with clinical outcomes (t = -2.35, p = 0.019). This evidence further supports that treatment interventions converge on a CDN in depression. Optimizing modulation of this network could serve to improve the outcome of neurostimulation in depression.

Indexed as

BrainDeep Brain StimulationElectroconvulsive TherapyMajor Depressive DisorderTranscranial Magnetic StimulationAdultAgedCohort StudiesDepressionFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedNerve NetNeuroimaging

Identifiers

PMID37985787
PMCPMC11116108
OpenAlexW4388827294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.